Accolade Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

NEW YORK–(BUSINESS WIRE)–Accolade Health, Inc. (“Accolade”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that on June 8, 2022 the Compensation Committee of Accolade’s Board of Directors approved the grant of inducement restricted stock unit awards covering 992,382 Class A shares of Accolade’s common stock to 29 new … [Read more…]

CONMED Completes Acquisition of In2Bones Global, Inc.

LARGO, Fla.–(BUSINESS WIRE)–CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc. Headquartered in Memphis, Tennessee, In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. … [Read more…]

Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47

NEW YORK & BOSTON & WILMINGTON, Del.–(BUSINESS WIRE)–Pfizer Inc. (NASDAQ:PFE), MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE: MOR; NASDAQ:MOR), and Incyte (NASDAQ:INCY) today announced a clinical trial collaboration and supply agreement to investigate the immunotherapeutic combination of Pfizer’s TTI-622, a novel SIRPα-Fc fusion protein, and Monjuvi® (tafasitamab-cxix) plus lenalidomide in patients … [Read more…]

Outset Medical Announces Shipment Hold on New Tablo Systems for Home Use Pending FDA Review and Clearance of Recent 510(K) Submission

Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “company”) today announced it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the Food and Drug Administration’s (FDA) review and clearance of a 510(k) the … [Read more…]

Tivic Health Announces Annual Meeting of Shareholders

SAN FRANCISCO–(BUSINESS WIRE)–Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the Annual General Meeting of Shareholders will be held on Tuesday, June 14, 2022, at 10:00 a.m., Pacific Daylight Time. The Company has adopted a virtual format for our Annual Meeting to provide a … [Read more…]

OIC Receives $15 Million Gift from Renee & Meyer Luskin; Now Known as The Luskin Orthopaedic Institute for Children

Largest Gift in the Organization’s 112-year History Helps Assure That Children With a Musculoskeletal Condition or Injury Have the Opportunity to Grow Well and Play Well LOS ANGELES–(BUSINESS WIRE)–#luskin–Orthopaedic Institute for Children announced today that it has received a $15 million gift from Renee & Meyer Luskin, the largest gift to the organization’s endowment in … [Read more…]

Rubedo Life Sciences Announces Expansion of Scientific Advisory Board

– Newly Appointed Members Include Judith Campisi, Ph.D., Mario Lacouture, M.D. and Francesca Grisoni, Ph.D. SUNNYVALE, Calif.–(BUSINESS WIRE)–Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies for chronic age-related diseases targeting senescent cells that drive cellular aging, today announced the appointments of Judith Campisi, Ph.D., Francesca Grisoni, Ph.D., and Mario Lacouture, M.D., to … [Read more…]

Valbiotis announces the major success of the Phase II HEART clinical study: the patented plant-based active substance TOTUM•070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor

This randomized, placebo-controlled Phase II clinical study with TOTUM•070 achieved its objective of reducing LDL cholesterol (primary endpoint) and confirmed the very good tolerance of this active substance. As early as 3 months of supplementation, the results showed a significant reduction in blood levels of LDL cholesterol (-13%) and triglycerides (-14%). Comprehensive data from the … [Read more…]

Arroyo Grande Community Hospital Partners with Kindred Rehabilitation Services for New Inpatient Rehabilitation Hospital

New facility will double the occupancy of the current rehabilitation center ARROYO GRANDE, Calif.–(BUSINESS WIRE)–Arroyo Grande Community Hospital (AGCH) and Kindred Rehabilitation Services (KRS), a business unit of LifePoint Health, today announced a joint venture to build and operate a new inpatient rehabilitation hospital on Dignity Health’s Arroyo Grande Community Hospital campus. The approximately 46,000-square-foot … [Read more…]

Global Clinical Trials Connect 2022: Two Day Virtual Summit, September 21-22, 2022 –

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trials Connect 2022” conference has been added to’s offering. The Global Clinical Trials Connect 2022 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This event is designed for senior-level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution providers … [Read more…]